Stifel Nicolaus Initiates Coverage On Bioverativ to Buy with Price Target $54

Stifel Nicolaus Initiates Coverage On Bioverativ(BIVVV). In a research note issued to the investors, the brokerage major Announces the price-target to $54 per share. The shares have been rated Buy. The rating by Stifel Nicolaus was issued on Feb 3, 2017.

In a different note, Morgan Stanley said it Initiates Coverage On Bioverativ, according to a research note issued on Feb 2, 2017. The shares have been rated ‘Underweight’ by the firm. Cowen & Co. said it Initiates Coverage On Bioverativ, according to a research note issued on Jan 27, 2017. The shares have been rated ‘Market Perform’ by the firm. Goldman Sachs said it Initiates Coverage On Bioverativ, according to a research note issued on Jan 27, 2017. The shares have been rated ‘Buy’ by the firm.

Share this post

Leave a Reply